See more : WISeKey International Holding AG (WSKEF) Income Statement Analysis – Financial Results
Complete financial analysis of Chong Kun Dang Holdings Corp. (001630.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chong Kun Dang Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Armadale Capital Plc (ACP.L) Income Statement Analysis – Financial Results
- SEL Manufacturing Company Limited (SELMCL.BO) Income Statement Analysis – Financial Results
- HHY Fund (HHY.AX) Income Statement Analysis – Financial Results
- SinoSun Technology Co. Ltd. (300333.SZ) Income Statement Analysis – Financial Results
- S & U PLC 6% CUM PRF #1 (46IE.L) Income Statement Analysis – Financial Results
Chong Kun Dang Holdings Corp. (001630.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Chong Kun Dang Holdings Corp.
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 879.78B | 908.96B | 925.98B | 858.12B | 720.64B | 531.11B | 450.74B | 335.68B | 221.83B | 181.40B | 560.62B | 595.43B | 569.16B | 526.72B | 452.47B | 381.59B | 316.99B |
| Cost of Revenue | 495.92B | 509.77B | 484.57B | 444.22B | 391.97B | 328.18B | 283.73B | 233.15B | 151.67B | 122.97B | 275.76B | 295.77B | 262.11B | 231.92B | 212.11B | 176.18B | 150.01B |
| Gross Profit | 383.86B | 399.19B | 441.41B | 413.90B | 328.67B | 202.93B | 167.00B | 102.53B | 70.17B | 58.43B | 284.86B | 299.66B | 307.05B | 294.80B | 240.35B | 205.41B | 166.98B |
| Gross Profit Ratio | 43.63% | 43.92% | 47.67% | 48.23% | 45.61% | 38.21% | 37.05% | 30.54% | 31.63% | 32.21% | 50.81% | 50.33% | 53.95% | 55.97% | 53.12% | 53.83% | 52.68% |
| Research & Development | 23.22B | 22.71B | 20.93B | 20.66B | 16.39B | 11.17B | 9.67B | 6.47B | 3.87B | 1.31B | 26.82B | 32.52B | 29.28B | 25.03B | 16.69B | 14.52B | 11.85B |
| General & Administrative | 27.41B | 25.69B | 22.82B | 8.11B | 8.67B | 7.28B | 7.38B | 6.45B | 4.27B | 2.40B | 20.35B | 23.66B | 22.06B | 23.90B | 15.74B | 15.20B | 13.07B |
| Selling & Marketing | 230.17B | 306.08B | 295.58B | 228.86B | 159.94B | 82.44B | 63.26B | 34.19B | 13.63B | 6.60B | 56.52B | 62.31B | 67.65B | 63.39B | 55.85B | 41.21B | 33.08B |
| SG&A | 327.49B | 331.77B | 318.40B | 236.97B | 168.61B | 89.72B | 70.64B | 40.63B | 17.90B | 9.00B | 76.88B | 85.97B | 89.71B | 87.29B | 71.59B | 56.41B | 46.15B |
| Other Expenses | 0.00 | 77.59B | 67.67B | 67.00B | 57.99B | 3.29B | 29.63B | 16.39B | 13.43B | 4.82B | 369.64B | 2.54B | 340.86M | 996.54M | 2.01B | -1.69B | -2.85B |
| Operating Expenses | 350.72B | 432.07B | 407.00B | 324.63B | 242.99B | 149.35B | 123.51B | 79.48B | 41.98B | 27.70B | 202.42B | 220.97B | 220.98B | 219.31B | 189.60B | 156.43B | 134.41B |
| Cost & Expenses | 846.63B | 941.84B | 891.56B | 768.86B | 634.96B | 477.53B | 407.24B | 312.63B | 193.65B | 150.67B | 478.18B | 516.74B | 483.09B | 451.23B | 401.71B | 332.62B | 284.42B |
| Interest Income | 2.45B | 1.61B | 803.83M | 1.26B | 1.68B | 1.67B | 1.40B | 1.19B | 1.13B | 1.12B | 1.76B | 3.12B | 2.60B | 1.69B | 1.29B | 2.00B | 1.42B |
| Interest Expense | 19.60B | 10.80B | 4.36B | 3.48B | 2.95B | 1.45B | 1.60B | 1.41B | 1.19B | 1.08B | 6.08B | 9.98B | 11.11B | 9.44B | 8.62B | 10.42B | 9.95B |
| Depreciation & Amortization | 45.28B | 42.94B | 35.74B | 30.35B | 27.51B | 24.15B | 24.07B | 16.68B | 8.77B | 7.29B | 21.19B | 19.10B | 15.57B | 13.84B | 13.05B | 12.08B | 14.98B |
| EBITDA | 62.28B | 13.61B | 70.15B | 119.40B | 113.67B | 77.83B | 67.57B | 39.72B | 36.13B | 38.02B | 103.63B | 102.15B | 105.84B | 91.25B | 66.36B | 54.46B | 54.05B |
| EBITDA Ratio | 7.08% | 2.87% | 7.69% | 19.07% | 17.60% | 16.54% | 23.37% | 20.07% | 20.19% | 25.19% | 84.48% | 17.03% | 18.51% | 17.64% | 14.67% | 14.76% | 16.73% |
| Operating Income | 33.15B | -16.88B | 34.41B | 133.32B | 86.16B | 53.72B | 43.50B | 23.05B | 28.18B | 30.73B | 82.44B | 78.69B | 87.35B | 75.49B | 50.76B | 48.97B | 32.57B |
| Operating Income Ratio | 3.77% | -1.86% | 3.72% | 15.54% | 11.96% | 10.11% | 9.65% | 6.87% | 12.70% | 16.94% | 14.71% | 13.22% | 15.35% | 14.33% | 11.22% | 12.83% | 10.28% |
| Total Other Income/Expenses | 10.56B | -5.73B | -6.51B | 45.21B | 11.95B | 13.71B | 30.40B | 22.63B | 4.07B | 1.44B | 357.75B | -6.65B | -8.21B | -7.52B | -11.76B | -17.05B | -3.46B |
| Income Before Tax | 43.71B | -24.71B | 27.90B | 143.99B | 98.11B | 67.39B | 79.24B | 48.88B | 32.97B | 36.66B | 446.85B | 72.06B | 79.15B | 67.97B | 38.99B | 31.93B | 29.12B |
| Income Before Tax Ratio | 4.97% | -2.72% | 3.01% | 16.78% | 13.61% | 12.69% | 17.58% | 14.56% | 14.86% | 20.21% | 79.71% | 12.10% | 13.91% | 12.90% | 8.62% | 8.37% | 9.19% |
| Income Tax Expense | 3.13B | -2.04B | 2.08B | 30.37B | 18.78B | 14.58B | 11.82B | 6.03B | 2.41B | 23.35B | 22.79B | 34.69B | 22.61B | 20.09B | 10.16B | 10.13B | 11.48B |
| Net Income | 47.01B | -22.66B | 25.82B | 113.62B | 79.33B | 27.46B | 48.01B | 29.43B | 15.21B | 9.46B | 415.74B | 32.01B | 53.53B | 44.25B | 25.69B | 21.64B | 19.86B |
| Net Income Ratio | 5.34% | -2.49% | 2.79% | 13.24% | 11.01% | 5.17% | 10.65% | 8.77% | 6.86% | 5.22% | 74.16% | 5.38% | 9.40% | 8.40% | 5.68% | 5.67% | 6.27% |
| EPS | 9.74K | -4.62K | 5.19K | 22.69K | 15.83K | 5.48K | 9.77K | 6.63K | 3.91K | 2.82K | 130.19K | 9.42K | 15.68K | 12.75K | 7.78K | 6.17K | 5.94K |
| EPS Diluted | 9.74K | -4.62K | 5.19K | 22.69K | 15.83K | 5.48K | 9.77K | 6.63K | 3.91K | 2.82K | 130.19K | 9.42K | 15.68K | 12.75K | 7.78K | 6.17K | 5.94K |
| Weighted Avg Shares Out | 4.82M | 4.91M | 4.98M | 5.01M | 5.01M | 5.01M | 4.92M | 4.44M | 3.89M | 3.35M | 3.19M | 3.40M | 3.41M | 3.47M | 3.30M | 3.51M | 3.34M |
| Weighted Avg Shares Out (Dil) | 4.82M | 4.91M | 4.98M | 5.01M | 5.01M | 5.01M | 4.92M | 4.44M | 3.89M | 3.35M | 3.19M | 3.40M | 3.41M | 3.47M | 3.30M | 3.51M | 3.34M |
No news found for: 001630.KS
Source: https://incomestatements.info
Category: Stock Reports